School of Medicine
Showing 21-40 of 81 Results
-
Benedikt Geier
Postdoctoral Scholar, Infectious Diseases
BioB.Sc. Biology, Ludwig Maximilian University (LMU), Munich/Germany (2013)
M.Sc. Biology and bioimaging, Ludwig Maximilian University (LMU), Munich/Germany (2015)
Ph.D., Animal-Microbe Symbioses, Max Planck Institute for Marine Microbiology in Bremen/Germany (2020)
Benedikt joined the Amieva Lab from Germany in 2022. During his B.Sc. and M.Sc. programs in zoology, he became fascinated with 3D imaging approaches to study small animal microanatomy. He spent his PhD developing in situ imaging approaches to study deep-sea symbioses and fell in love with studying host-microbe interactions. In the Amieva Lab, Benedikt will advance his previously developed correlative chemical imaging techniques to resolve metabolic and cellular interactions that drive H. pylori pathogenesis in the gastric glands.
More about Benedikt's transition from deep-sea microbiology into infectious disease research can be found here:
https://scopeblog.stanford.edu/2022/08/24/unconventional-paths-deep-sea-to-the-stomach/ -
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
-
Rachel Gilgoff
Adjunct Clinical Associate Professor, Pediatrics - Allergy and Clinical Immunology
BioAs a board-certified general pediatrician, child abuse pediatrician, and integrative medicine specialist, Dr. Gilgoff brings a multidisciplinary, whole-family approach to ACEs, toxic stress, healing, and well-being. She is currently an advisor with the California Aces Aware Initiative, UCLA-UCSF ACEs Aware Family Resilience Network (UCAAN), and the Center for Youth Wellness, a program of Safe and Sound, as well as an Adjunct Clinical Associate Professor at Stanford University School of Medicine. She is the co-founder of the National Committee on Asthma and Toxic Stress and co-PI on “Systems-based, Multidisciplinary Assessment of Adversity and Toxic Stress for Individualized Care (The SYSTEMAATIC Project),” an ACEs and Precision Medicine research project through the California Initiative to Advance Precision Medicine (CIAPM). She co-created the “Stress Busters: Clinical Strategies for Preventing and Mitigating Toxic Stress,” a free, on-line course to help clinicians develop their clinical response to childhood adversity and toxic stress. In tandem, she led the development of the ACEs Aware Stress Busters Resource Webpage, sharing tools and resources to prevent and heal toxic stress for all of us. Dr. Gilgoff is dedicated to conducting translational research and promoting patient-centered, individualized, multidisciplinary clinical care to address health issues resulting from child abuse and toxic stress.
Board Certification:
American Board of Physician Specialties, Integrative Medicine (2022)
American Board of Pediatrics, Child Abuse Pediatrics (2011)
American Board of Pediatrics, General Pediatrics (2004)
Professional Education
Fellowship:
Integrative Psychiatry Institute, Integrative Psychiatry (2023)
Andrew Weil Center for Integrative Medicine (2022)
Stanford University Medical Center, Pediatric Integrative Medicine (2021)
UCSF Benioff Children’s Hospital Oakland and UC Davis, Child Abuse Pediatrics (2007)
Residency:
UCSF Benioff Children’s Hospital and Research Center at Oakland (2004)
Medical Education:
Keck School of Medicine, USC (2001) -
Bertil Glader
Stanford Medicine Professor of Pediatric Hematology/Oncology, Emeritus
Current Research and Scholarly InterestsHematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary coagulation disorders-clinical trials.
-
Greg Glasscock
Clinical Associate Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsNeonatal Endocrinology
-
Anna L Gloyn
Professor of Pediatrics (Endocrinology) and of Genetics
Current Research and Scholarly InterestsAnna's current research projects are focused on the translation of genetic association signals for type 2 diabetes and glycaemic traits into cellular and molecular mechanisms for beta-cell dysfunction and diabetes. Her group uses a variety of complementary approaches, including human genetics, functional genomics, physiology and islet-biology to dissect out the molecular mechanisms driving disease pathogenesis.
